Hypoxia-inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 9, 2009, Pages 904-911

  Tan, Tao ^a   Luciano, Jason A ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Calcium transients; Cardiac myocytes; Contractility; Hypoxia inducible factor 1; Ischaemia reperfusion; New Zealand white rabbit

Indexed keywords

DEFEROXAMINE; FORSKOLIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OUABAIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART MUSCLE CELL; HYPOTHESIS; ISCHEMIA; LEISURE; MUSCLE FIBER CONTRACTION; NONHUMAN; RABBIT; REPERFUSION INJURY; SIMULATION; STUNNED HEART MUSCLE; UPREGULATION;

ANIMALS; ANTIFUNGAL AGENTS; CALCIUM SIGNALING; CARDIOTONIC AGENTS; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON CHELATING AGENTS; MYOCARDIAL CONTRACTION; MYOCARDIAL STUNNING; MYOCYTES, CARDIAC; OUABAIN; PYRIDONES; RABBITS; REPERFUSION INJURY; TIME FACTORS; UP-REGULATION;

EID: 69949091358     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05165.x     Document Type: Article

References (39)

1. Paul SA, Simons JW, Mabjeesh NJ. HIF at the crossroads between ischemia and carcinogenesis. J. Cell Physiol. 2004 200 : 20 30.
2. Semenza GL. HIF-1 and human disease: One highly involved factor. Genes Dev. 2000 14 : 1983 1991.
3. Semenza GL. Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology 2004 19 : 176 182.
4. Poellinger L, Johnson RS. HIF-1 and hypoxic response: The plot thickens. Curr. Opin. Genet. Dev. 2004 14 : 81 5.
5. Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 2005 37 : 535 540.
6. 2-regulated gene expression: Transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 2004 96 : 1173 1177.
7. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part 2. Circulation 2001 104 : 3158 3167.
8. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 1999 79 : 609 634.
9. Depre C, Vatner SF. Cardioprotection in stunned and hibernating myocardium. Heart Fail. Rev. 2007 12 : 307 317.
10. Leone Jr RJ, Scholz PM, Weiss HR. Nitroprusside attenuates myocardial stunning through reduced contractile delay and time. Proc. Soc. Exp. Biol. Med. 2000 223 : 263 269.
11. Moalem J, Davidov T, Katz E, Scholz PM, Weiss HR. Atrial natriuretic peptide reverses the negative functional effects of stunning in rabbit myocardium. Regul. Pept. 2005 132 : 47 52.
12. Tse J, Gandhi A, Yan L, He YQ, Weiss HR. Effects of triiodothyronine pretreatment on beta-adrenergic responses in stunned cardiac myocytes. J. Cardiothorac. Vasc. Anesth. 2003 17 : 486 490.
13. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ. Res. 1995 76 : 1036 1048.
14. Kemi OJ, Ellingsen O, Smith GL, Wisloff U. Exercise-induced changes in calcium handling in left ventricular cardiomyocytes. Front. Biosci. 2008 13 : 356 368.
15. Chi NC, Karliner JS. Molecular determinants of responses to myocardial ischemia/reperfusion injury: Focus on hypoxia-inducible and heat shock factors. Cardiovasc. Res. 2004 61 : 437 447.
16. Date T, Mochizuki S, Belanger AJ et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am. J. Physiol. Cell Physiol. 2005 288 : C314 20.
17. Cai Z, Manalo DJ, Wei G et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003 108 : 79 85.
18. Jurgensen JS, Rosenberger C, Wiesener MS et al. Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J. 2004 18 : 1415 1417.
19. Lefer DJ. Induction of HIF-1alpha and iNOS with siRNA: A novel mechanism for myocardial protection. Circ. Res. 2006 98 : 10 11.
20. Nagle DG, Zhou YD. Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1). Curr. Pharm. Des. 2006 12 : 2673 2688.
21. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler 3rd AA. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ. Res. 2006 98 : 133 140.
22. Wilhide ME, Jones WK. Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element. Mol. Pharmacol. 2006 69 : 1773 1778.
23. Zhang Q, Lazar M, Yan L et al. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms. J. Cardiovasc. Pharmacol. 2004 44 : 235 243.
24. Ren J, Wold LE. Measurement of cardiac mechanical function in isolated ventricular myocytes from rats and mice by computerized video-based imaging. Biol. Proced. Online 2001 3 : 43 53.
25. Zhu H, Cai C, Chen J. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1. FEBS Lett. 2004 576 : 369 374. (Pubitemid 39388630)
26. 2-adrenergic signal transduction. Circ. Res. 1999 85 : 1092 1100.
27. Thandroyen FT, Muntz KH, Buja LM, Willerson JT. Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion. Circulation 1990 82 : II30 7.
28. McDonough AA, Velotta JB, Schwinger RH, Philipson KD, Farley RA. The cardiac sodium pump: Structure and function. Basic Res. Cardiol. 2002 97 (Suppl. 1 I19 24.
29. Luciano JA, Tan T, Zhang Q, Huang E, Scholz P, Weiss HR. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell Physiol. Biochem. 2008 21 : 421 428.
30. Dworschak M, Breukelmann D, Hannon JD. The effect of isoflurane during reoxygenation on the sarcoplasmic reticulum and cellular injury in isolated ventricular myocytes. Life Sci. 2006 78 : 888 893.
31. Straznicka M, Scholz PM, Gong G, Weiss HR. Nitroprusside reverses lengthened time of contraction in stunned canine cardiac myocytes. J. Cardiovasc. Pharmacol. 2000 35 : 219 226.
32. Angelos MG, Murray HN, Waite MD, Gorsline RT. Postischemic inotropic support of the dysfunctional heart. Crit. Care Med. 2002 30 : 410 416.
33. Yoo KY, Kim H, Jeong CW, Park HC, Bae HB, Lee J. Effects of inotropic drugs on mechanical function and oxygen balance in postischemic canine myocardium: Comparison of dobutamine, epinephrine, amrinone, and calcium chloride. J. Korean Med. Sci. 2005 20 : 732 739.
34. O'Brien JD, Ferguson JH, Howlett SE. Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2008 294 : H2174 83.
35. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 2001 12 : 363 369.
36. Sandau KB, Faus HG, Brune B. Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Biochem. Biophys. Res. Commun. 2000 278 : 263 267.
37. Zundel W, Schindler C, Haas-Kogan D et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 2000 14 : 391 396.
38. Ning XH, Chen SH, Buroker NE et al. Short-cycle hypoxia in the intact heart: Hypoxia-inducible factor 1alpha signaling and the relationship to injury threshold. Am. J. Physiol. Heart Circ. Physiol. 2007 292 : H333 41.
39. Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am. J. Physiol. Heart Circ. Physiol. 2008 294 : H901 8.